Zeeuwen P L, Hendriks W, de Jong W W, Schalkwijk J
Department of Dermatology, Institute of Cellular Signaling, University of Nijmegen, P. O. Box 9101, 6500 HB Nijmegen, The Netherlands.
J Biol Chem. 1997 Aug 15;272(33):20471-8. doi: 10.1074/jbc.272.33.20471.
The human epithelial proteinase inhibitor SKALP/elafin and the porcine sodium-potassium ATPase inhibitor SPAI-2 are two highly homologous proteins that share an NH2-terminal transglutaminase substrate domain and a COOH-terminal whey acidic protein (WAP) domain. Here we describe the bovine and simian orthologs of SKALP/elafin as well as two new bovine family members that are designated Trappin-4 and Trappin-5 on the basis of a new nomenclature that we propose (Trappin = TRansglutaminase substrate and WAP motif-containing ProteIN). Sequence analysis of Trappin-4 and Trappin-5 revealed a domain structure that is very similar to SPAI-2 (Trappin-1) and SKALP/elafin (Trappin-2). The transglutaminase substrate motifs are conserved although the number of repeats varies among species and among family members. The sequence of Trappin-4 and Trappin-5 diverges from Trappin-1 and Trappin-2 at the putative reactive site in the WAP domain. The bovine ortholog of Trappin-2 is expressed in tongue and snout epidermis; Trappin-4 is expressed in trachea, ileum, and tongue; and Trappin-5 is expressed at low levels in trachea, as determined by RNase protection and Northern blot analysis. Based on the analysis of 67 transglutaminase substrate repeats as present in all known Trappin gene family members from four different mammalian species a consensus sequence could be established: Gly-Gln-Asp-Pro-Val-Lys (GQDPVK). Using biotinylated hexapeptide probes we found that the GQDPVK sequence is a very efficient transglutaminase substrate both for guinea pig liver transglutaminase and for epidermal transglutaminase, and it acts as acyl donor as well as acceptor. We propose that the Trappin protein family forms a new group of enzyme inhibitors with various specificities of the WAP domain, which share transglutaminase substrate motifs that can act as an anchoring sequence.
人上皮蛋白酶抑制剂SKALP/elafin和猪钠钾ATP酶抑制剂SPAI-2是两种高度同源的蛋白质,它们共享一个NH2末端转谷氨酰胺酶底物结构域和一个COOH末端乳清酸性蛋白(WAP)结构域。在此,我们描述了SKALP/elafin的牛和猴直系同源物,以及两个新的牛家族成员,根据我们提出的新命名法(Trappin = 含转谷氨酰胺酶底物和WAP基序的蛋白质)将它们命名为Trappin-4和Trappin-5。对Trappin-4和Trappin-5的序列分析揭示了一种与SPAI-2(Trappin-1)和SKALP/elafin(Trappin-2)非常相似的结构域结构。转谷氨酰胺酶底物基序是保守的,尽管重复次数在物种间和家族成员间有所不同。Trappin-4和Trappin-5的序列在WAP结构域的假定反应位点与Trappin-1和Trappin-2不同。通过核糖核酸酶保护和Northern印迹分析确定,Trappin-2的牛直系同源物在舌和口鼻表皮中表达;Trappin-4在气管、回肠和舌中表达;Trappin-5在气管中低水平表达。基于对来自四种不同哺乳动物物种的所有已知Trappin基因家族成员中存在的67个转谷氨酰胺酶底物重复序列的分析,可以建立一个共有序列:甘氨酸-谷氨酰胺-天冬氨酸-脯氨酸-缬氨酸-赖氨酸(GQDPVK)。使用生物素化的六肽探针,我们发现GQDPVK序列对于豚鼠肝脏转谷氨酰胺酶和表皮转谷氨酰胺酶都是非常有效的转谷氨酰胺酶底物,并且它既作为酰基供体又作为受体。我们提出,Trappin蛋白家族形成了一组新的酶抑制剂,其WAP结构域具有各种特异性,它们共享可作为锚定序列的转谷氨酰胺酶底物基序。